... The company is backed by Biomark Capital, a life sciences and healthcare investment firm with offices in Greenwich, CT and San Francisco, CA. Investor and media contact: Douglas D. Lind, MD Interim Chief Executive Officer Opus Bio, Inc. (203) ...
http://www.freshnews.com/news/976419/lentigen-corporation-announces-sale-lentiviral-vector-manufacturing-business-and-change
http://www.freshnews.com/news/976419/lentigen-corporation-announces-sale-lentiviral-vector-manufacturing-business-and-change
No comments:
Post a Comment